Acaya 100mg Capsule

Acaya 100mg Capsule

Prescription requiredRx Required

Salt Composition: Acalabrutinib

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

mantle cell lymphoma

About The Product

small lymphocytic lymphoma,  chronic lymphocytic leukemia,  mantle cell lymphoma

Description

Acaya 100mg capsule an anti-cancer medication. It is used in the treatment of blood cancer of all three types such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL).

Acaya 100mg capsule active ingredient is Acalabrutinib which belongs to the drug class of Bruton's tyrosine kinase (BTK) inhibitor which helps by inhibiting the growth of malignant blood cells by interfering with their DNA replication, thereby slowing disease progression and supporting remission. Doctors do not prescribe this medication below the age of 18 to ensure safety and effectiveness of the treatment.

Indication

Small lymphocytic leukemia (SLL), Mantle cell lymphoma (MCL) and Chronic lymphocytic leukemia (CLL)

Common side effects

  • Every medication has several side effects and it is important to be aware of them before starting any treatment.
  • Common ones are: ● Anemia ● Low blood platelets ● Headache ● Diarrhea ● Neutrophils ● Infections ● Fatigue ● Skin reaction

Dosage and administration

  • Acaya 100mg capsule should be taken with food or between foods at the fixed time everyday without avoid missing doses.
  • It should be used only under the prescription of the doctor to ensure safety and effectiveness of the medication.
  • The medication may take several weeks or months to see the results.
  • Inform the doctor if you have any medical history of bleeding disorders, heart or liver disease or if you are taking any other medications or supplements, so they can adjust the treatment effectively.

Mechanism of action

Acaya 100mg capsule work by blocking or inhibiting Bruton's tyrosine kinase (BTK), a protein that play a vital role in the normal development of B cells that helps the body fight infection by producing antibodies.

Therefore, the medication stops the growth of cancer cells and protects the body from further growing cancer in the body.

Safety advice

Alcohol
While taking Acaya 100mg capsule, avoid using alcohol as it may interfere with the treatment and making it less effective in controlling the disease.
Driving
Acaya 100mg capsule show side effects such as dizziness and sleepiness, doctors do not suggest driving at the time of treatment.
Pregnancy
Pregnant women avoid taking Acaya 100mg capsule as it contains a potent anti-cancer agent that may harm the developing fetus.
Breast Feeding
Acaya 100mg capsule is not recommended to breastfeeding women because it may pass into breast milk and harm the nursing infant.
Kidney
Patient with a kidney cancer avoid taking Acaya 100mg capsule because this medication is specifically designed to treat certain cancers.
Liver
Acaya 100mg capsule is not recommended to liver patients because impaired liver functions can affect how the medication is processed in the body.

FAQs

Acaya 100mg capsule is taken by the patient of mantle cell lymphoma, small lymphocytic lymphoma and chronic lymphocytic leukemia, all type of blood cancer.

Reference

• Panigrahi, H. N.

(2025). A new stability indicating RP-HPLC method for the estimation of Acalabrutinib.

Research Journal of Pharmacy and Technology, 18(5), 2349-2355. • Das, P. P., Banerjee, S., & Bose, S.

(2024). Impact of the Asian Spider Flower (Cleome viscosa) on Human Health.

In Medicinal Spices and Herbs from India (pp. 133-143).

Apple Academic Press. • Ventosa-Febles, E. (2022).

Cleome gynandra (wild spider flower). CABI Compendium.

CABI International. doi, 10. • Wolska-Washer, A., & Robak, T. (2022).

Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia. Expert Review of Hematology, 15(3), 183-194. • Byrd, J.

C., Wierda, W. G., Schuh, A., Devereux, S., Chaves, J.

M., Brown, J. R., ... & Furman, R.

R. (2020).

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results. Blood, 135(15), 1204-1213.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026